Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement
The UCLA Radiological Science Proceedings · 2025
DOI: 10.5070/rs4.35505 ↗Kurz gefasst
Fachartikel in der Zeitschrift The UCLA Radiological Science Proceedings, 2025. Verfasst von Claire Lis und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amiodarone is an effective class III antiarrhythmic medication, the use of which is limited by its potentially severe side effects and toxicities. When amiodarone pulmonary toxicity (APT) is suspected in patients, amiodarone use should be discontinued. We report a case of APT, with a description of the clinical presentation and radiologic manifestations of the disease and a literature review of purported pathophysiology and treatment.
Zitieren
APA
Lis, C., & Pourzand, L. (2025). Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement. The UCLA Radiological Science Proceedings. https://doi.org/10.5070/rs4.35505
Vancouver
Lis C, Pourzand L. Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement. The UCLA Radiological Science Proceedings. 2025. doi:10.5070/rs4.35505
BibTeX
@article{Lis2025,
author = {Lis, Claire and Pourzand, Lila},
title = {Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement},
journal = {The UCLA Radiological Science Proceedings},
year = {2025},
doi = {10.5070/rs4.35505}
}
EUVIMED